Total returns on £1000
1Y
- 3M
- 6M
- 1Y
- 3Y
- 5Y
Fund/benchmark | Change | |
---|---|---|
Price | Syncona Limited (Ordinary Share) | -28.24% |
NAV | Syncona Limited (Ordinary Share) | -2.35% |
Morningstar's Benchmark | FTSE 250 TR GBP | -- |
Announcements
- Transaction in Own Shares
- Freeline presents clinical data update
- Achilles reports Q1 2024 Financial Results
- Total Voting Rights
- Century Therapeutics to acquire Clade Therapeutics
- Achilles reports full year 2023 Financial Results
- Achilles provides clinical data update
- Autolus reports full year 2023 Financial Results
- Director Declaration
- Acquisition of Freeline Becomes Effective
More ▼
Key statistics
On Thursday, Syncona Limited (SYNC:LSE) closed at 110.20, 4.95% above its 52-week low of 105.00, set on Sep 28, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Shares outstanding | 651.66m |
---|---|
Market cap | 726.82m GBP |
Total assets | 1.23bn GBP |
Total expense ratio | 0.92% |
High | 111.40 |
Low | 109.80 |
Previous close | 111.60 |
Average volume | 727.30k |
---|---|
YTD Change | -10.70% |
Beta | 0.2883 |
Diluted NAV (est) | 188.20 |
Diluted NAV (last pub) | 188.20 |
Premium/Discount | -41.45% |
Net Gearing | 0.00% |
Data delayed at least 20 minutes, as of May 16 2024 16:35 BST.
More ▼